Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene
<p>Abstract</p> <p>Background</p> <p>Desmoid tumour is a benign, non metastasising neoplasm characterised by an elevated deposition of organic macromolecules in the extracellular matrix (ECM). The matrix metalloproteinases (MMPs) are a family of zinc-dependent proteinas...
Main Authors: | Becchetti Alessio, Giustozzi Giammario, Marinucci Lorella, Stabellini Giordano, Lilli Cinzia, Balducci Chiara, Cagini Lucio, Locci Paola |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-03-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/5/22 |
Similar Items
-
Three benefits of toremifene, or a trend in the current hormone therapy
by: E. I. Borisova, et al.
Published: (2015-12-01) -
Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
by: Jaime D. Lewis, et al.
Published: (2014-11-01) -
Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer
by: Dandan Song, et al.
Published: (2021-07-01) -
High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases
by: Ryutaro Mori, et al.
Published: (2014-06-01) -
Tumor desmoide abdômino-pélvico Abdominopelvic desmoid tumor
by: Fernando Antonio Mourão Valejo, et al.
Published: (2009-01-01)